Published in March 2019, , titled Low Endotoxin Recovery , is a definitive industry resource for addressing one of the most challenging phenomena in modern biopharmaceutical quality control.
Why it matters: These advances make PDAs more practical for real-time edge analytics, autonomous systems, and compact industrial controllers—enabling higher performance without sacrificing energy or reliability.
Essential for demonstrating the absence of LER in all BLA submissions containing surfactants.
Published in March 2019, , titled Low Endotoxin Recovery , is a definitive industry resource for addressing one of the most challenging phenomena in modern biopharmaceutical quality control.
Why it matters: These advances make PDAs more practical for real-time edge analytics, autonomous systems, and compact industrial controllers—enabling higher performance without sacrificing energy or reliability.
Essential for demonstrating the absence of LER in all BLA submissions containing surfactants.
